Vamstar, the AI-powered commercial intelligence platform reshaping MedTech and Pharma operations, is set to headline MedTech Forum 2025 in Lisbon with a landmark session titled “AI Unleashed: Strengthening MedTech Competitiveness in a New Industrial Age.” The talk promises to reframe artificial intelligence not as a future-facing concept, but as a critical commercial lever for MedTech organizations contending with Europe’s intricate healthcare landscape.
The session, led by Praful Mehta, CEO of Vamstar, and Richard Charter, Senior Advisor, will offer a comprehensive roadmap to reverse declining industry returns and tackle deep-rooted inefficiencies. Against the backdrop of regulatory drag, talent attrition, and shrinking margins, Vamstar’s leaders argue that a failure to execute on AI now could leave traditional players vulnerable to faster, leaner disruptors.
“Execution risk is the new existential threat for MedTech,” warned Mehta. “AI is the only viable equalizer—offering speed, precision, and scale—if deployed with strategic clarity across procurement, pricing, sales, and market access.”
The presentation will center on five key AI-driven imperatives for MedTech transformation:
-
AI as the P&L Engine: Moving beyond isolated pilots to deploy AI across sales, tendering, and contracting to unlock EBITDA.
-
Avoiding Commoditisation: Enabling hardware-focused firms to evolve into hybrid, AI-powered service platforms.
-
Winning with AI-Native GTM Models: Outperforming legacy competitors with faster automation and hyper-personalized engagement.
-
Governance Now, Not Later: Codifying GenAI workflows to avoid Shadow AI risks, IP fragmentation, and audit failures.
-
Strategic AI Deployment: Prioritizing high-margin functions and under-leveraged regions—not just following volume.
The urgency behind the message is clear. As diagnostics and devices face commoditisation risk, high-growth verticals like digital health and AI-driven robotics are pulling ahead. Without bold moves, Vamstar warns, legacy players could be left behind.
“This is no longer a technology discussion—it’s about survival and long-term relevance,” said Charter. “The gap between AI dabblers and AI winners is widening every quarter.”
Vamstar’s appearance at MedTech Forum underscores its commitment to enabling a more intelligent, adaptive, and commercially resilient MedTech sector powered by real-time AI integration.
